183 related articles for article (PubMed ID: 32598517)
1. Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
Chen SW; Lu HP; Chen G; Yang J; Huang WY; Wang XM; Huang SP; Gao L; Liu J; Fu ZW; Chen P; Zhai GQ; Luo J; Li XJ; Huang ZG; Li ZY; Gan TQ; Yang DP; Mo WJ; Zhou HF
FEBS Open Bio; 2020 Aug; 10(8):1624-1641. PubMed ID: 32598517
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
7. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
9. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract][Full Text] [Related]
10. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.
Huang SP; Jiang YF; Yang LJ; Yang J; Liang MT; Zhou HF; Luo J; Yang DP; Mo WJ; Chen G; Shi L; Gan TQ
Cancer Biother Radiopharm; 2022 Mar; 37(2):125-140. PubMed ID: 32614608
[No Abstract] [Full Text] [Related]
12. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
13. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
14. Construction of Prognostic Model and miRNA-mRNA Regulatory Network for Lung Squamous Cell Carcinoma.
Zhao L; Fu Q; Shi M; Zhang H
Altern Ther Health Med; 2024 Feb; 30(2):183-187. PubMed ID: 37856813
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
16. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
17. Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma.
Ye Z; Sun B; Xiao Z
Gene; 2020 Jul; 749():144669. PubMed ID: 32298761
[TBL] [Abstract][Full Text] [Related]
18. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
[TBL] [Abstract][Full Text] [Related]
20. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
